Πλοήγηση ανά Συγγραφέα "Gioulbasanis, I."
-
Baseline Insulin-Like Growth Factor-I Plasma Levels, Systemic Inflammation, Weight Loss and Clinical Outcome in Metastatic Non-Small Cell Lung Cancer Patients
Vlachostergios, P. J.; Gioulbasanis, I.; Kamposioras, K.; Georgoulias, P.; Baracos, V. E.; Ghosh, S.; Maragouli, E.; Georgoulias, V.; Papandreou, C. N. (2011)Background: Cancer patients frequently suffer from weight loss and systemic inflammation in the context of advanced disease, which is related to adverse outcome. Insulin-like growth factor (IGF)-I is an anabolic molecule ... -
The Glasgow Prognostic Score (GPS) predicts toxicity and efficacy in platinum-based treated patients with metastatic lung cancer
Gioulbasanis, I.; Pallis, A.; Vlachostergios, P. J.; Xyrafas, A.; Giannousi, Z.; Perdikouri, I. E.; Makridou, M.; Kakalou, D.; Georgoulias, V. (2012)Purpose: Lung cancer is the most common cause of cancer death. A cumulative prognostic score based on C-reactive protein and albumin, termed the Glasgow Prognostic Score (GPS), indicates the presence of systemic inflammatory ... -
Predictive and prognostic value of LPS-stimulated cytokine secretion in metastatic non-small cell lung cancer
Vlachostergios, P. J.; Gioulbasanis, I.; Ghosh, S.; Tsatsanis, C.; Papatsibas, G.; Xyrafas, A.; Hatzidaki, E.; Vasiliou, C.; Kamposioras, K.; Agelaki, S.; Margioris, A. N.; Nasi, D.; Georgoulias, V.; Papandreou, C. N. (2013)Cancer patients usually develop malnutrition which may alter their innate immune system integrity. The aim of this study was to investigate the clinical relevance of chemokine response after lipopolysaccharide (LPS)-stimulation ... -
Selecting for predisposition to cancer cachexia
Gioulbasanis, I.; Vlachostergios, P. J.; Papandreou, C. N. (2012)